Fasting and Refeeding to Study Body Weight in Obesity and Low Weight
Tests a 2-day fast then refeeding in adults with obesity or underweight.
Key facts
- Who runs it
- Pennington Biomedical Research Center
- Where
- Baton Rouge, United StatesSee the site
- Trial code
- Registry title
- Experimental Approach to Test Predictions of Body Weight Regulation Models
- Status
- Recruiting
- People taking part
- 12 people, planned
- Started
- 17 Jan 2025
- Expected to end
- 3 Dec 2026
- Type of study
- Interventional
- Treatments tested
- Fasting-refeeding cycle
- Record updated
- 29 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men and women aged 18-40 who either have low body weight or obesity. They will fast for 2 days, then eat freely for 2 days, in a metabolic chamber.
- Age
- 18 to 40 years
- Sex
- Men and women
- Disease stage
- Low body weight group: body mass index lower than 20 kg/m2. Obesity group: body mass index 30 kg/m2 or greater.
- Earlier treatment
- Must not use medications that may affect energy intake or expenditure, such as semaglutide, liraglutide, exenatide, other GLP-1 receptor agonists, phentermine-topiramate, naltrexone-bupropion, orlistat, metformin or SGLT2 inhibitors.
- Biomarker or test result
- Normal thyroid function, blood count and chemistry 15 panel. Weight stable over the last six months (±3 kg (7 lb)). Women: regular menstrual cycle (25-35 days) over the last six months.
Main reasons for not taking part
- Eating disorder, or a score of 2.80 or more on the Eating Disorder Examination Questionnaire
- Smoking cigarettes or vaping, or more than 14 alcoholic drinks per week
- Regular recreational exercise of 150 minutes per week or more, or being a professional athlete
- Diseases that affect energy balance, such as thyroid disease, diabetes, cancer, heart, lung or kidney disease
- Currently pregnant or breastfeeding, or using oral hormonal contraceptives (women)
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Body mass index lower than 20 kg/m2 for the low body weight group, or 30 kg/m2 or greater for the obesity group
- 18-40 years old
- Nulliparous and regular menstrual cycle (25-35 days) during the last six months (in women)
- Normal thyroid function, blood count, and chemistry 15 panel (normal plasma glucose will be considered at <100 mg/dL; normal serum HDL cholesterol at >=50 mg/dL for women and >=40 mg/dL for men; and normal serum triglycerides at <150 mg/dL)
- Self-reported weight stability during the last six months (±3 kg)
- Rate the liking of at least one of the flavored liquid meals (Ensure Plus, Abbot Nutrition) between 5 and 8 on a 9-point Likert scale
- Willing to only drink up to two assigned flavors of Ensure Plus for two consecutive days
Who cannot take part
- Eating disorders as indicated by a global score ≥2.80 in the Eating Disorder Examination Questionnaire, or a previous diagnosis of an eating disorder
- Use of medications that may affect energy intake and/or expenditure, for example, semaglutide, liraglutide, exenatide, other GLP-1 receptor agonists, phentermine-topiramate, naltrexone-bupropion, orlistat, metformin, SGLT2 inhibitors, pramlintide, levocarnitine, amphetamines, and amphetamine-like drugs
- Diseases that affect energy homeostasis including endocrine such as hypo/hyperthyroidism, or type 1 or 2 diabetes; cancer; chronic pulmonary diseases; cardiovascular disease; and renal disease
- History of inflammatory bowel disease (ulcerative colitis, Crohn's), malabsorption syndromes (intestinal, pancreatic), and sprue or gluten intolerance
- For the low body weight group, having food insecurity (with or without hunger) as assessed by the USDA
- Recreational moderate-intensity physical activity ≥150 min/week, recreational vigorous-intensity physical activity ≥75 min/week, or a combination of recreational moderate-intensity and vigorous-intensity physical activity (moderate time + [2 × vigorous time]) ≥150 min/week as assessed by the Global Physical Activity Questionnaire, or being a professional athlete
- Cigarette or vape smoking
- Intake of more than 14 alcoholic drinks per week
- Human immunodeficiency virus, galactosemia, and lactose intolerance
- Having moderate to severe sleep apnea defined as an oxygen desaturation index \>10 times/hour assessed by overnight oximetry to be conducted on the night following the screening visit
- Use of oral hormonal contraceptives or less than 6 months using a hormonal intrauterine device (in women)
- Adults who are unable to consent
- Prisoners
- Currently pregnant or breastfeeding (in women)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Where in United States
- Pennington Biomedical Research CenterBaton Rouge, United StatesContact: Rodrigo Fernández-Verdejo, PhDTaking people
About the trial
What the trial wants to find out
The regulation of human body weight and fatness is not fully understood. Although some models of regulation have been proposed (set point, dual-intervention point, others), no studies have been designed to test their predictions. In this pilot and feasibility study, the investigators will implement an experimental approach to test the predictions of models of body weight regulation in humans. Men and women with either low body weight or obesity will be exposed to a 2-day fasting followed by a 2-day ad-libitum refeeding. During the entire fasting-refeeding period, energy intake and expenditure will be accurately measured within metabolic chambers. The investigators will therefore determine the compensatory responses to fasting elicited to prevent weight loss. The results will serve to design and power future studies to better understand body weight regulation.
The group in the trial
- Fasting-refeeding cycleTreatment being tested
Participants will be maintained in metabolic chambers and exposed to 1 day of energy balance, 2 days of fasting, and 2 days of ad-libitum refeeding.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Experimental Approach to Test Predictions of Body Weight Regulation Models
- Plain-language title
- Fasting and Refeeding to Study Body Weight in Obesity and Low WeightGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06309576, who can take part
- Record updated
- 29 May 2026